Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy
- PMID: 11896114
- DOI: 10.1200/JCO.2002.20.6.1635
Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy
Abstract
Purpose: The goal of three-dimensional (3-D) conformal radiation is to increase the dose delivered to tumor while minimizing dose to surrounding normal brain. Previously it has been shown that even escalated doses of 70 to 80 Gy have failure patterns that are predominantly local. This article describes the failure patterns and survival seen with high-grade gliomas given 90 Gy using a 3-D conformal intensity-modulated radiation technique.
Patients and methods: From April 1996 to April 1999, 34 patients with supratentorial high-grade gliomas were treated to 90 Gy. For those that recurred, failure patterns were defined in terms of percentage of recurrent tumor located within the high-dose region. Recurrences with more than 95% of their volume within the high-dose region were considered central; those with 80% to 95%, 20% to 80%, and less than 20% were considered in-field, marginal, and distant, respectively.
Results: The median age was 55 years, and median follow-up was 11.7 months. At time of analysis, 23 (67.6%) of 34 patients had developed radiographic evidence of recurrence. The patterns of failure were 18 (78%) of 23 central, three (13%) of 23 in-field, two (9%) of 23 marginal, and zero (0%) of 23 distant. The median survival was 11.7 months, with 1-year survival of 47.1% and 2-year survival of 12.9%. No significant treatment toxicities were observed.
Conclusion: Despite dose escalation to 90 Gy, the predominant failure pattern in high-grade gliomas remains local. This suggests that close margins used in highly conformal treatments do not increase the risk of marginal or distant recurrences. Our results indicate that intensification of local radiotherapy with dose escalation is feasible and deserves further evaluation for high-grade gliomas.
Comment in
-
Conformal radiotherapy for high-grade gliomas: how much is too much?J Clin Oncol. 2002 Aug 1;20(15):3357-8; author reply 3359. doi: 10.1200/JCO.2002.99.102. J Clin Oncol. 2002. PMID: 12149313 No abstract available.
-
Radiotherapy dose escalation in high-grade gliomas.J Clin Oncol. 2002 Aug 1;20(15):3358-9; author reply 3359. doi: 10.1200/JCO.2002.99.802. J Clin Oncol. 2002. PMID: 12149315 No abstract available.
Similar articles
-
Patterns of failure following high-dose 3-D conformal radiotherapy for high-grade astrocytomas: a quantitative dosimetric study.Int J Radiat Oncol Biol Phys. 1999 Jan 1;43(1):79-88. doi: 10.1016/s0360-3016(98)00266-1. Int J Radiat Oncol Biol Phys. 1999. PMID: 9989517
-
Low grade gliomas: preliminary analysis of failure patterns among patients treated using 3D conformal external beam irradiation.Int J Radiat Oncol Biol Phys. 1995 Feb 1;31(3):461-6. doi: 10.1016/0360-3016(94)00400-F. Int J Radiat Oncol Biol Phys. 1995. PMID: 7852107
-
Radiotherapy dose escalation in high-grade gliomas.J Clin Oncol. 2002 Aug 1;20(15):3358-9; author reply 3359. doi: 10.1200/JCO.2002.99.802. J Clin Oncol. 2002. PMID: 12149315 No abstract available.
-
[Iridium 192 brachytherapy of supra-tentorial high grade glioma recurring in irradiated areas: technique and preliminary results of the Pitié-Salpêtrière hospital group].Bull Cancer Radiother. 1996;83(3):144-52. Bull Cancer Radiother. 1996. PMID: 8977564 Review. French.
-
Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?Strahlenther Onkol. 2004 Jul;180(7):401-7. doi: 10.1007/s00066-004-1220-7. Strahlenther Onkol. 2004. PMID: 15241527 Review.
Cited by
-
Effects of the DRD2/3 antagonist ONC201 and radiation in glioblastoma.Radiother Oncol. 2021 Aug;161:140-147. doi: 10.1016/j.radonc.2021.05.027. Epub 2021 Jun 5. Radiother Oncol. 2021. PMID: 34097975 Free PMC article.
-
Hypofractionated radiotherapy for glioblastoma: strategy for poor-risk patients or hope for the future?Br J Radiol. 2012 Sep;85(1017):e770-81. doi: 10.1259/bjr/83827377. Br J Radiol. 2012. PMID: 22919020 Free PMC article. Review.
-
The Definition and Delineation of the Target Area of Radiotherapy Based on the Recurrence Pattern of Glioblastoma After Temozolomide Chemoradiotherapy.Front Oncol. 2021 Feb 22;10:615368. doi: 10.3389/fonc.2020.615368. eCollection 2020. Front Oncol. 2021. PMID: 33692942 Free PMC article.
-
Integration method of 3D MR spectroscopy into treatment planning system for glioblastoma IMRT dose painting with integrated simultaneous boost.Radiat Oncol. 2013 Jan 2;8:1. doi: 10.1186/1748-717X-8-1. Radiat Oncol. 2013. PMID: 23280007 Free PMC article.
-
Recurrence pattern of glioblastoma treated with intensity-modulated radiation therapy versus three-dimensional conformal radiation therapy.Radiat Oncol J. 2024 Sep;42(3):218-227. doi: 10.3857/roj.2024.00381. Epub 2024 Sep 26. Radiat Oncol J. 2024. PMID: 39354825 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous